Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1223-1228, March 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarez, H. G.
Right arrow Articles by Sarasin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarez, H. G.
Right arrow Articles by Sarasin, A.

Activated Oncogenes in Human Skin Tumors from a Repair-deficient Syndrome, Xeroderma Pigmentosum1

Horacio G. Suarez, Leela Daya-Grosjean, Daniel Schlaifer, Pierre Nardeux, Georges Renault, Johannes L. Bos and Alain Sarasin2

Institut de Recherches Scientifiques sur le Cancer, B.P. no. 8, 94802—Villejuif, France [H. G. S., L. D-G., D. S., P. N., G. R., A. S.], and the Dept of Medical Biochemistry, Sylvius Laboratories, P. O. Box 9503, 2300 RA, Leiden, Holland [J. L. B.]

The recessive autosomal hereditary disease, xeroderma pigmentosum (XP), is characterized by a high incidence of tumors in sun-exposed skin. The defect in early steps of excision repair of XP cells leads to hypermutability towards UV-mimicking agents. DNA from eight XP tumors were screened for activated transforming genes using 3T3 transfection. In two skin tumors isolated from a XP child, an activated N-ras oncogene was detected. Synthetic oligonucleotide probes were used to characterize the mutation in the ras gene. Both tumors were found to be mutated in the 61st N-ras codon from gln to his. The mutation was accompanied by an increase in the level of N-ras specific mRNA and in one transformant, by the alteration of the p21 protein. In the same tumors, c-myc amplification and over transcription, and Ha-ras gene rearrangement and amplification were also detected. Analysis of other XP tumors with eleven different oncogene probes revealed an amplification of the Ha-ras gene in 6 out of 10 cases. The normal skin fibroblasts from XP patients show normal pattern levels of N-ras, c-myc and Ha-ras sequences. The hypothesis is proposed that the presence of several oncogene alterations in the same tumor could be due to the high amount of UV-induced DNA lesions found in the exposed skin cells, in the absence of efficient repair.

1 This work has been supported by grants to H. Suarez and A. Sarasin from the Association pour la Recherche sur le Cancer (Villejuif, France), from the Fondation pour la Recherche Médicale (Paris, France), from C.N.R.S. (95-9040), and from the Commission of the European Communities (BI6-163-F, Brussels, Belgium).

2 To whom requests for reprints should be addressed.

Received 6/ 7/88. Revised 9/16/88. Accepted 11/ 8/88.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. V. D'Elia, G. Tell, D. Russo, F. Arturi, F. Puglisi, G. Manfioletti, V. Gattei, D. L. Mack, P. Cataldi, S. Filetti, et al.
Expression and Localization of the Homeodomain-Containing Protein HEX in Human Thyroid Tumors
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1376 - 1383.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Arturi, D. Russo, M. Schlumberger, J.-A. du Villard, B. Caillou, P. Vigneri, R. Wicker, E. Chiefari, H. G. Suarez, and S. Filetti
Iodide Symporter Gene Expression in Human Thyroid Tumors
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2493 - 2496.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
D A Spandidos, G Sourvinos, H Kiaris, and J Tsamparlakis
Microsatellite instability and loss of heterozygosity in human pterygia
Br. J. Ophthalmol., June 1, 1997; 81(6): 493 - 496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.